October 13th 2025
A deep learning AI platform, which incorporated radiomic features including CT attenuation metrics, demonstrated a 93.6 percent AUC for detecting invasive adenocarcinoma on chest CT.
Seven Takeaways from Lung-RADS 2022 for CT Lung Cancer Screening
November 10th 2022In the newly released Lung-RADS 2022 classification system for computed tomography (CT) lung cancer screening, the American College of Radiology (ACR) has noted a variety of updates including new classification criteria for atypical pulmonary cysts and airway nodules, time intervals for nodule growth and a new stepped management approach for Lung-RADS categories 3 and 4A.
Study Shows Less Than 50 Percent Adherence to Follow-Up After Positive CT Findings for Lung Cancer
November 4th 2022In a multicenter study of 685 people who had positive findings for lung cancer on low-dose computed tomography (CT), researchers found that men, Black individuals, and smokers had lower rates of adherence with recommended follow-up care.
Recognizing the Role of Enterprise Imaging in Handling and Protecting Sensitive Patient Information
October 19th 2022While facilitating interdisciplinary colloaboration is a central objective with enterprise imaging platforms, this author says implementation of these platforms must ensure optimal patient privacy in sensitive cases involving abuse, assault and domestic violence.
GE Healthcare Launches Omni Legend PET/CT System at EANM Congress
October 17th 2022The inclusion of digital bismuth germanate (BGO) detector material with the Omni Legend system reportedly more than doubles the sensitivity of older PET/CT devices, improves scan times, and enhances the detection of small lesions.
Can Increased Post-Op Surveillance Chest CT Have an Impact for Colorectal Cancer Patients?
October 17th 2022Out of 1,600 patients who had surgery for colorectal cancer, nearly 15 percent had pulmonary metastases within 15.4 months and higher-risk patients experienced lung metastases within three months, according to new research presented at the Scientific Forum of the American College of Surgeons Clinical Congress.
GE Healthcare Announces Moves to Bolster Supply of Iodinated Contrast Media for CT and X-Ray Imaging
October 14th 2022A multi-year agreement with a large Chile-based supplier of raw iodine is part of GE Healthcare’s commitment to increase the production of iodinated contrast media, commonly used in computed tomography imaging, by 30 million annually in 2025.
Study Looks at Potential Impact of Expanded Eligibility for Low-Dose CT Lung Cancer Screening
October 6th 2022Modifications to pack-year history and smoking quit duration thresholds beyond those recommended in the 2021 United States Preventative Services Task Force (USPSTF) criteria for low-dose computed tomography lung cancer screening may more than double the number of increased lung cancer cases physicians would see with application of the 2021 USPSTF screening criteria.
A Closer Look at Ultrasound and MRI Alternatives for Head and Neck Imaging
September 29th 2022In light of recent shortages of iodinated contrast media, researchers from Australia suggest in a new publication that ultrasound and magnetic resonance imaging (MRI) can be viable first-line imaging options for a number of non-urgent presentations of the head and neck.
Could a New Deep Learning Tool Enhance CT Detection of Pancreatic Cancer?
September 13th 2022New research reveals that an emerging deep learning tool had comparable sensitivity and specificity to radiologist assessment of contrast-enhanced computed tomography (CT) scans for pancreatic cancer, and a 74.7 percent sensitivity rate for tumors smaller than 2 cm.
Managing Incidentalomas in Radiology: Embracing Challenges as Opportunities
September 12th 2022Greater imaging utilization has increased the prevalence of incidental findings or incidentalomas, but unclear clinical context and guidelines complicate management. Accordingly, these authors offer a thorough review of the literature and discuss new opportunities for improving interdisciplinary management strategies.
New Study Suggests Lung-Related Comorbidities Have No Impact on Lung Cancer Detection
September 8th 2022Comparing patients with and without comorbidities ranging from emphysema and tuberculosis to chronic obstructive pulmonary disease (COPD), researchers found that cancer detection rates and false-positive rates remained similar in lung cancer screening.
Will a New Spectral CT Imaging Suite Reinvent Interventional Radiology?
September 7th 2022Amid emerging research showing the benefits of spectral computed tomography (CT) imaging in interventional radiology, the newly launched Phillips Spectral Angio CT Suite may provide enhanced efficiencies in care for stroke, oncology, and trauma patients.
Emerging AI CT Tool May Provide Viable Complement to Lung-RADS Classification
September 6th 2022Researchers suggest that an artificial intelligence (AI)-powered risk stratification tool for lung nodules identified on computed tomography (CT) scans may identify likely malignancies more than one year prior to definitive diagnosis.
Judy Yee, MD, FACR Receives Gold Medal Honors from the Society of Abdominal Radiology
August 24th 2022Well known for her education and advocacy on the use of computed tomography (CT) colonography for colorectal cancer screening, Dr. Yee is also widely recognized for her leadership, mentoring skills and being a champion for diversity in the field of radiology.
MRI/CT Imaging for Axillary Lymph Nodes: What a New Breast Cancer Study Reveals
August 16th 2022The combination of magnetic resonance imaging (MRI) and computed tomography (CT) had a 63.83 percent sensitivity rate for tumor-infiltrated axillary lymph nodes in patients with breast cancer in comparison to a 36.11 percent sensitivity rate for the combination of mammography and sonography.